Sensitive and selective liquid chromatography-electrospray ionisation-mass spectrometry analysis of astragaloside-IV in rat plasma

被引:34
作者
Huang, CR [1 ]
Wang, GJ [1 ]
Li, H [1 ]
Xie, HT [1 ]
Sun, HG [1 ]
Lv, H [1 ]
Lv, T [1 ]
机构
[1] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China
关键词
astragaloside-IV; LC-ESI-MS; pharmacokinetics;
D O I
10.1016/j.jpba.2005.10.015
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Astragaloside-IV (3-O-beta-D-xylopyranosyl-6-O-beta-D-glueopyranosyl-cycloastragenol) is the major active constituent contained in Radix Astragali. This paper describes a rapid, sensitive and specific assay for quantitative determination of astragaloside-IV in rat plasma. After a liquid/liquid extraction (LLE) with n-butanol and high-performance liquid chromatography (HPLC) gradient separation with acetonitrile-NH4Cl solution (0.5 mu mol/L) as the mobile phase, the anions adduct [M + Cl](-) at m/z 819.4 of astragaloside-IV, and [M + Cl](-) at m/z 815.35 of internal standard (IS) digoxin were analyzed by electrospray ionisation-mass spectrometry (LC-ESI-MS) in selected ion monitoring (SIM) mode. Chromatographic separation was achieved in less than 9 min and calibration curve was linear over a concentration range of 2-200 ng/ml. The described assay method was successfully applied to the preclinical pharmacokinetic study of astragaloside-IV. After intragastric administration of astragaloside-IV to rats, Cmax and Tmax of astragaloside-IV were 134.73 +/- 39.86 ng/ml and 1.5 h, respectively, and the elimination half-life (t(1/2)) was 5.45 +/- 0.39 h. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:788 / 793
页数:6
相关论文
共 15 条
[1]  
ABDALLAH RM, 1993, PHARMAZIE, V48, P452
[2]  
Bedir E, 2000, BIOL PHARM BULL, V23, P834, DOI 10.1248/bpb.23.834
[3]   Determination of Astragaloside IV in rat plasma by liquid chromatography electrospray ionization mass spectrometry [J].
Gu, YC ;
Wang, GJ ;
Fawcett, JP .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 801 (02) :285-288
[4]  
Kinjo J, 2000, BIOL PHARM BULL, V23, P887, DOI 10.1248/bpb.23.887
[5]   Astragaloside IV protects against ischemia brain injury in a murine model of transient focal ischemia [J].
Luo, YM ;
Qin, Z ;
Hong, Z ;
Zhang, XM ;
Ding, D ;
Fu, JH ;
Zhang, WD ;
Chen, J .
NEUROSCIENCE LETTERS, 2004, 363 (03) :218-223
[6]  
Ma Z, 1999, Zhong Yao Cai, V22, P303
[7]  
Wang Jingzhu, 1998, Zhongguo Zhongyao Zazhi, V23, P84
[8]   Quantitation of astragaloside IV in rat plasma by liquid chromatography-tandem mass spectrometry [J].
Yan, LX ;
Guo, DA .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 824 (1-2) :244-248
[9]  
Yang Q, 2001, ACTA PHARMACOL SIN, V22, P809
[10]   A precolumn derivatization high-performance liquid chromatographic method with improved sensitivity and specificity for the determination of astragaloside IV in Radix astragali [J].
Yao, MC ;
Qi, Y ;
Bi, KS ;
Wang, X ;
Luo, X ;
Che, CT .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2000, 38 (08) :325-328